Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia.

Journal of lipid research - 1 Jun 1999

Groenendijk M, Cantor R M, Blom N H, Rotter J I, de Bruin T W, Dallinga-Thie G M

Abstract excerpt

The apoAI-CIII-AIV gene cluster, located on chromosome 11, contributes to the phenotype of familial combined hyperlipidemia (FCH), but this contribution is genetically complex. Combinations of haplotypes, based on three restriction enzyme polymorphisms: XmnI and MspI sites, 5' of the start site of the apoA-I gene and SstI polymorphism in the 3' untranslated region of exon 4 of the apoC-III gene, were analyzed to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-I
Share to Apolipoprotein C-III

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoproteins

Share to Apolipoproteins A

Share to Apolipoproteins C

Share to Hyperlipidemia, Familial Combined

Share to Lipids

Share to Response Elements

Source

Identifiers

PMID: 10357835

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia.PMID 10357835Read ↗

Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.Semantic proximity Read ↗

Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia.Semantic proximity Read ↗

New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia.Semantic proximity Read ↗

Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin.Semantic proximity Read ↗

Two polymorphisms in the apo A-IV gene and familial combined hyperlipidemia.Semantic proximity Read ↗

Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.Semantic proximity Read ↗

Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia.Semantic proximity Read ↗

Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis.Semantic proximity Read ↗

Novel genes for familial combined hyperlipidemia.Semantic proximity Read ↗

Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population.Semantic proximity Read ↗

Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.Semantic proximity Read ↗

Apolipoprotein AI and CIII gene polymorphisms and their association with lipid levels in Italian, Greek and Anglo-Irish populations of Australia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.